Inhibition of ULK1/2 and KRASG12C controls tumor growth in preclinical models of lung cancer
Phaedra C. Ghazi(University of Utah), Martin McMahon(University of Utah)
Cited by 11
Related Papers
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
|Nature|2013|735
Resiliency and Vulnerability in the HER2-HER3 Tumorigenic Driver
|Science Translational Medicine|2010|185
p53 constrains progression to anaplastic thyroid carcinoma in a <i>Braf</i> -mutant mouse model of papillary thyroid cancer
|Proceedings of the National Academy of Sciences|2014|169
Oncogenic BRAF<sup>V600E</sup> inhibits BIM expression to promote melanoma cell survival
|Pigment Cell & Melanoma Research|2008|116
Isolation and Molecular Characterization of Circulating Melanoma Cells
|Cell Reports|2014|109